Detalhe da pesquisa
1.
Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion.
Cancer Immunol Immunother
; 72(12): 4001-4014, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37973660
2.
PEPITEM modulates leukocyte trafficking to reduce obesity-induced inflammation.
Clin Exp Immunol
; 212(1): 1-10, 2023 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891817
3.
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function.
Ann Rheum Dis
; 82(11): 1415-1428, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580108
4.
Interplay in galectin expression predicts patient outcomes in a spatially restricted manner in PDAC.
Biomed Pharmacother
; 172: 116283, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38377735
5.
Therapeutic avenues in bone repair: Harnessing an anabolic osteopeptide, PEPITEM, to boost bone growth and prevent bone loss.
Cell Rep Med
; 5(5): 101574, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38776873
6.
Bench to Bedside: Modelling Inflammatory Arthritis.
Discov Immunol
; 2(1): kyac010, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38567064
7.
Expression of CYP1A1 and GSTP1 in human brain tumor tissues in Pakistan.
Asian Pac J Cancer Prev
; 14(12): 7187-91, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24460273